[Comment] Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma
Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, London W12 0HS, UKDivision of Molecular Pathology and Centre for Evolution and Cancer, The Institute of Cancer Research, London, UKDepartment of Medicine, The Royal Marsden NHS Trust, London, UK
Comments (0)